If RAD was acquired for $250 million the pps would be $32 usd for RADX. So basically 700% upside… I think that would be an entry level acquisition cost. With stellar data on a phase 2 would be $1.5 million. Lantheus owns the pd-l1 imaging asset from NanoMab and Rad owns the therapeutic. Data mid year!
Partner Lantheus acquired Evergreen for $250 million usd
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.003(8.82%) |
Mkt cap ! $73.31M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.1¢ | $58.95K | 1.821M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 783888 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 870662 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| RAD (ASX) Chart |